Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication.
Introduction
Company name: Virbac Limited
Address: Woolpit Business Park
Windmill Avenue
Woolpit
Bury St Edmunds
Suffolk
IP30 9UP
Telephone: 01359 243243
Fax: 01359 243200
Website: www.virbac.co.uk
Presentation
White, circular, biconcave tablet with brown spots.
Each chewable tablet of 3300mg contains 20mg ivermectin.
Uses
For the treatment of nematode and arthropod infestations, due to adult and immature roundworms and bots in horses:
Nematodes
Large-strongyles:
Strongylus vulgaris (adult and arterial larvae)
Strongylus edentatus (adult and L4 tissue larval stages)
Strongylus equinus (adult and L4 larval stage)
Triodontophorus spp. (adult)
Small-strongyles:
Cyathostomum (adult and non-encysted mucosal larvae): Cylicocyclus spp., Cylicostephanus spp., Gyalocephalus spp.
Parascaris: Parascaris equorum (adult and larvae).
Oxyuris: Oxyuris equi (adult and larvae).
Trichostrongylus: Trichostrongylus axei (adult).
Dipteran insects
Gasterophilus spp. (larvae).
Dosage and administration
Single oral administration.
200 µg of ivermectin per kg of bodyweight corresponding to 1 tablet per 100 kg bodyweight.
To ensure a correct dosage, bodyweight should be determined as accurately as possible.
Once the correct dose has been determined, it should be administered in the following way :
Present the tablet in the palm of your hand.
Presenting one tablet at a time makes it easier for the horse to accept it, however the administration of multiple tablets at once is also possible.
Repeat this gesture until the complete dose has been administered.
During the initial administration, the tablet can be combined with a small amount of food or a treat to increase the acceptance by the horse.
In the event that the required dose is not ingested an alternative treatment should be administered. Seek the advice of your veterinary surgeon.
The veterinary surgeon should give advice regarding appropriate dosing programmes and stock management to achieve adequate parasite control for both roundworm and bot infestations.
Contra-indications, warnings, etc
Do not use in foals under 2 weeks of age. Do not use in horses known to be hypersensitive to the active ingredient or any of the other ingredients.
Colic, diarrhoea and anorexia have been reported in very rare occasions post treatment, in particular when there is heavy worm burden. In very rare occasions, allergic reactions such as hypersalivation, lingual oedema, urticaria, tachycardia, congested mucus membranes, and subcutaneous oedema have been reported following treatment with the product.
Special precautions for use in animals
Avermectins may not be well tolerated in non target species. Cases of intolerance are reported in dogs, especially Collies, Old English Sheepdogs and related breeds or crosses, and also in turtles and tortoises.
Dogs and cats should not be allowed to ingest spilled tablet or have access to used packaging due to the potential for adverse effects related to ivermectin toxicity.
Young foals, miniature horses and toy breeds weighing less than 50 kg may be unable to ingest tablets. Seek the advice of your veterinary surgeon.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Wash hands after use. Avoid contact with the eyes. In case of eye irritation, seek medical attention. Do not eat, drink or smoke while handling this product. In the event of accidental ingestion, seek medical advice and show the leaflet to the physician so that he knows what you have taken.
Special warnings for target species
Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: too frequent and repeated use of anthelmintics from the same class over an extended period of time, underdosing, which may be due to underestimation of body weight, misadministration of the product, or lack of calibration of the dosing device (if any).
Suspected clinical cases of resistance to anthelmintics should be further investigated using appropriate tests (e.g. Faecal Egg Count Reduction Test). Where the results of the test(s) strongly suggest resistance to a particular anthelmintic, an anthelmintic belonging to another pharmacological class and having a different mode of action should be used.
Resistance to ivermectin has been reported in Parascaris equorum in horses. Therefore the use of this product should be based on local (regional, farm) epidemiological information about susceptibility of nematodes and recommendations on how to limit further selection for resistance to anthelmintics.
The product is safe for use in stallions.
Overdose
A tolerance study performed with the product in adult horses with doses up to 5 times the recommended dosage did not show any adverse reactions.
Safety studies were conducted with a veterinary medicinal product containing praziquantel and the same dose of ivermectin (EQUIMAX oral gel), in mares, stallions and foals.
Administration to mares at 3 times the recommended dosage at 14-day intervals during the whole gestation and lactation periods did not result in any abortion, nor any adverse effect during gestation, at parturition or on the mares general health, nor any abnormality in the foals.
Administration to stallions at 3 times the recommended dosage did not show any adverse effect in particular on the reproductive performances.
Administration to foals with doses up to 5 times the recommended dosage did not show any adverse reaction.
Withdrawal period: Horses may be slaughtered for human consumption only after 35 days from the last treatment. Not to be used in horse producing milk for human consumption
Container disposal: Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. EXTREMELY DANGEROUS TO FISH AND AQUATIC LIFE. Do not contaminate surface waters or ditches with the product or used container.
Pharmaceutical precautions
This veterinary medicinal product does not require any special storage condition.
Do not use after the expiry date stated on the box.
Once opened, use the product within 12 months.
Keep out of the reach and sight of children.
Legal category
POM-VPS
Packaging Quantities
Carton box containing 1, 2, 12, 40 or 48 polypropylene tubes of 8 tablets closed by a polyethylene child proof cap.
Not all pack sizes may be marketed.
Further information
No known interaction with other equine medicaments.
Marketing authorisation number
Vm 05653/4159.
Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication.
Introduction
Company name: Virbac Limited
Address: Woolpit Business Park
Windmill Avenue
Woolpit
Bury St Edmunds
Suffolk
IP30 9UP
Telephone: 01359 243243
Fax: 01359 243200
Website: www.virbac.co.uk
Presentation
A white homogenous paste containing 1.87% w/w ivermectin Ph.Eur.
Uses
For the treatment and control of adult and immature gastrointestinal roundworms, lungworms and bots of horses, including:
Large strongyles
Strongylus vulgaris adults and 4th larval (arterial) stages
Strongylus edentatus adults and 4th larval (tissue) stages
Strongylus equinus adults
Small strongyles, adults
Cyathostomum spp.
Cylicocyclus spp.
Cylicodontophorus spp.
Cylicostephanus spp.
Gyalocephalus spp.
Hairworms
Trichostrongylus axei adults
Pinworms
Oxyuris equi adults and immatures
Ascarids
Parascaris equorum adults
Intestinal threadworms
Strongyloides westeri adults
Large-mouth stomach worms
Habronema muscae adults
Neck threadworms
Onchocerca spp. (microfilariae)
Lungworms
Dictyocaulus arnfieldi adult and immature
Stomach bots
Gasterophilus spp. oral and gastric larval stages
Dosage and administration
ERAQUELL paste is given by mouth at the recommended dose rate of 200 micrograms per kg of bodyweight as a single dose. Each syringe division delivers sufficient paste to treat 100kg of bodyweight (corresponding to 1.07g product and 20mg ivermectin). Each syringe delivers 140mg ivermectin, sufficient to treat 700kg of bodyweight.
The horse’s weight should be accurately determined to ensure use of the correct dose of product.
The animal’s mouth must be free of food. The syringe should be placed between the front and back teeth and the paste deposited at the base of the tongue. Immediately elevate the head for a few seconds to ensure that the product is swallowed. Re-treatment should be carried out according to the epidemiological situation and at not less than 30 day intervals. Eraquell may be used in pregnant mares.
Contra-indications, warnings, etc
For animal treatment only.
Not to be used in mares producing milk for human consumption.
Some horses carrying heavy infection of Onchocerca microfilariae have experienced reactions with swelling and itching after treatment. It is assumed to be the result of death of large numbers of microfilariae.
These signs resolve within a few days but symptomatic treatment may be advisable.
Eraquell has been formulated specifically for use in horses. Dogs and cats may be adversely affected by the concentration of ivermectin in this product, if they are allowed to ingest spilled paste or have access to used syringes.
As ivermectin is extremely dangerous to fish and aquatic life, treated animals should not have direct access to surface water and ditches during treatment.
Wash hands after use.
Avoid eye contact.
Do not smoke or eat while handling the product.
Withdrawal period
Horses may be slaughtered for human consumption only after 30 days from the last treatment.
Container disposal
Any unused product or waste material should be disposed of in accordance with local requirements. Ivermectin is EXTREMELY DANGEROUS TO FISH AND AQUATIC LIFE. Do not contaminate surface water or ditches with the product or used containers.
Pharmaceutical precautions
Keep out of the reach of children. Store below 30° C.
Legal category
POM-VPS
Packaging Quantities
12 syringes, each containing 7.49g of 1.87% w/w ivermectin paste
Further information
No known interaction with other equine medicaments.
Marketing authorisation number
Vm 16971/4005.
Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication.
Introduction
Company name: Virbac Limited
Address: Woolpit Business Park
Windmill Avenue
Woolpit
Bury St Edmunds
Suffolk
IP30 9UP
Telephone: 01359 243243
Fax: 01359 243200
Website: www.virbac.co.uk
Presentation
A white homogenous paste containing 1.87% w/w ivermectin Ph.Eur.
Uses
For the treatment and control of adult and immature gastrointestinal roundworms, lungworms and bots of horses, including:
Large strongyles
Strongylus vulgaris adults and 4th larval (arterial) stages
Strongylus edentatus adults and 4th larval (tissue) stages
Strongylus equinus adults
Small strongyles, adults
Cyathostomum spp.
Cylicocyclus spp.
Cylicodontophorus spp.
Cylicostephanus spp.
Gyalocephalus spp.
Hairworms
Trichostrongylus axei adults
Pinworms
Oxyuris equi adults and immatures
Ascarids
Parascaris equorum adults
Intestinal threadworms
Strongyloides westeri adults
Large-mouth stomach worms
Habronema muscae adults
Neck threadworms
Onchocerca spp. (microfilariae)
Lungworms
Dictyocaulus arnfieldi adult and immature
Stomach bots
Gasterophilus spp. oral and gastric larval stages
Dosage and administration
ERAQUELL paste is given by mouth at the recommended dose rate of 200 micrograms per kg of bodyweight as a single dose. Each syringe division delivers sufficient paste to treat 100kg of bodyweight (corresponding to 1.07g product and 20mg ivermectin). Each syringe delivers 140mg ivermectin, sufficient to treat 700kg of bodyweight.
The horse’s weight should be accurately determined to ensure use of the correct dose of product.
The animal’s mouth must be free of food. The syringe should be placed between the front and back teeth and the paste deposited at the base of the tongue. Immediately elevate the head for a few seconds to ensure that the product is swallowed. Re-treatment should be carried out according to the epidemiological situation and at not less than 30 day intervals. Eraquell may be used in pregnant mares.
Contra-indications, warnings, etc
For animal treatment only.
Not to be used in mares producing milk for human consumption.
Some horses carrying heavy infection of Onchocerca microfilariae have experienced reactions with swelling and itching after treatment. It is assumed to be the result of death of large numbers of microfilariae.
These signs resolve within a few days but symptomatic treatment may be advisable.
Eraquell has been formulated specifically for use in horses. Dogs and cats may be adversely affected by the concentration of ivermectin in this product, if they are allowed to ingest spilled paste or have access to used syringes.
As ivermectin is extremely dangerous to fish and aquatic life, treated animals should not have direct access to surface water and ditches during treatment.
Wash hands after use.
Avoid eye contact.
Do not smoke or eat while handling the product.
Withdrawal period
Horses may be slaughtered for human consumption only after 30 days from the last treatment.
Container disposal
Any unused product or waste material should be disposed of in accordance with local requirements. Ivermectin is EXTREMELY DANGEROUS TO FISH AND AQUATIC LIFE. Do not contaminate surface water or ditches with the product or used containers.
Pharmaceutical precautions
Keep out of the reach of children. Store below 30° C.
Legal category
POM-VPS
Packaging Quantities
12 syringes, each containing 7.49g of 1.87% w/w ivermectin paste
Further information
No known interaction with other equine medicaments.
Marketing authorisation number
Vm 16971/4005.
